<scp>PIONEER REAL Spain</scp> : A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes
Oral semaglutide treatment improved glycaemic control and reduced body weight in Spanish clinical practice. Early intervention and SGLT2i co-treatment were associated with more favourable outcomes.
Authors
- José Antonio Gómez Valero (ORCID: https://orcid.org/0000-0001-6186-0846)
- Alberto Aliaga Verdugo (ORCID: https://orcid.org/0000-0002-4717-4345)
- A.M. Piera Carbonell (ORCID: https://orcid.org/0000-0003-3948-0833)
- Cristina Abreu (ORCID: https://orcid.org/0000-0002-9238-443X)
- Cristóbal Morales (ORCID: https://orcid.org/0000-0003-0348-826X)
- Elías Delgado (ORCID: https://orcid.org/0000-0001-6114-9712)
- Stine H. Scheuer (ORCID: https://orcid.org/0000-0002-1244-9871)
- Christina Louise Rasmussen (ORCID: https://orcid.org/0000-0003-3920-373X)
- Diego Bellido (ORCID: https://orcid.org/0000-0003-0631-2710)
- Verónica López (ORCID: https://orcid.org/0000-0001-7405-3859)
- Amparo Gonzalez (ORCID: https://orcid.org/0000-0002-7657-433X)
Institutions
- Universidad de Oviedo (ES)
- Novo Nordisk (Denmark) (DK)
- Gobierno del Principado de Asturias (ES)
- Hospital General De Segovia (ES)
- Sociedad Española de Endocrinología y Nutrición (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital de Galdakao (ES)
- Novo Nordisk (India) (IN)
- Hospital Monte Naranco (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1111/dom.16523
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47
Funders
- Novo Nordisk